Baricitinib Acetic Acid Impurity
CAS: 2271228-52-3
Rif. TR-P852230
1mg | Fuori produzione | ||
5mg | Fuori produzione | ||
10mg | Fuori produzione |
Informazioni sul prodotto
- 3-Azetidineacetic acid
- 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]- (ACI)
- 1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetic acid (ACI)
- 2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetic acid
Applications 2-(3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetic Acid is an impurity of Baricitinib (B118690), which is a JAK1 and JAK2 inhibitor and has been studied as a promising treatment for rheumatoid arthritis.
References Dasari, S., et. al.: Russ. J. Org., 55, 1569 (2019);Zhang, F., et. al.: Faming Zhuanli Shenqing 11pp. Patent (2018), CN 108976233 A 20181211;Greenwald, L., et. al.: Int. J. Clin. Rheumatol., 6, 401 (2011); Fridman, J., et. al.: J. Immunol., 184, 5298 (2010);